Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: Rationale and design of the HoT-PE Trial

1. Barco, S.
2. Lankeit, M.
3. Binder, H.
4. Schellong, S.
5. Christ, M.
6. Beyer-Westendorf, J.
7. Duerschmied, D.
8. Bauersachs, R.
9. Empen, K.
10. Held, M.
11. Schwaiblmair, M.
12. Fonseca, C.
13. Jiménez, D.
14. Becattini, C.
15. Quitzau, K.
16. Konstantinides, S.